Close

Aprea Therapeutics (APRE) Treatment of Acute Myeloid Leukemia Receives FDA Orphan Status

Go back to Aprea Therapeutics (APRE) Treatment of Acute Myeloid Leukemia Receives FDA Orphan Status
Aperture Health, Inc. (NASDAQ: APRE) Delayed: 6.07 --0 (-0%)
Previous Close $6.07    52 Week High $0.08 
Open $6.07    52 Week Low $0.00 
Day High $6.07    P/E N/A 
Day Low $6.07    EPS $0.00 
Volume 11